RNA editome imbalance in hepatocellular carcinoma.

RNA editome imbalance in hepatocellular carcinoma.

Item
http://www.wikidata.org/entity/Q38189960
Alternative splicing of human NT5E in cirrhosis and hepatocellular carcinoma produces a negative regulator of ecto-5'-nucleotidase (CD73).Genetic Determinants of RNA Editing Levels of ADAR Targets in Drosophila melanogasterRNA editing-dependent epitranscriptome diversity in cancer stem cells.ADAR1 Activation Drives Leukemia Stem Cell Self-Renewal by Impairing Let-7 Biogenesis.An RNA editing/dsRNA binding-independent gene regulatory mechanism of ADARs and its clinical implication in cancer.Epitranscriptomic profiling across cell types reveals associations between APOBEC1-mediated RNA editing, gene expression outcomes, and cellular function.Circular RNA expression is suppressed by androgen receptor (AR)-regulated adenosine deaminase that acts on RNA (ADAR1) in human hepatocellular carcinoma.Organ-wide profiling in mouse reveals high editing levels of Filamin B mRNA in the musculoskeletal systemCircular RNAs: Characteristics, Function and Clinical Significance in Hepatocellular Carcinoma
P2860

RNA editome imbalance in hepatocellular carcinoma.

Item
http://www.wikidata.org/entity/Q38189960
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
RNA editome imbalance in hepatocellular carcinoma.
@en
type
label
RNA editome imbalance in hepatocellular carcinoma.
@en
prefLabel
RNA editome imbalance in hepatocellular carcinoma.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P356
P1433
P1476
RNA editome imbalance in hepatocellular carcinoma
@en
P2093
P304
P31
P356
10.1158/0008-5472.CAN-13-3485
P407
P433
P478
P50
P577
P698